Circē Skincare

Pharmaceutical Manufacturing • Irving, Texas, United States • 1-10 Employees

Company overview

Headquarters	Irving, Texas, United States
Website	circeskincare.com
NAICS	3254
Keywords	Skincare
Employees	1-10

Key Contact at Circē Skincare

Patricia Finn

FOUNDER | CEO

Circē Skincare Email Formats

Circē Skincare uses 1 email format. The most common is {first name} (e.g., john@circeskincare.com), used 100% of the time.

Format	Example	Percentage
{first name}	john@circeskincare.com	100%

About Circē Skincare

Circē Skincare delivers high-performance, results-driven formulations specifically designed to support dermatologic and aesthetic procedures. Products are hermetically sealed to maintain optimal potency and prevent contamination, while active ingredients like Vitamin C and Retinol are assay-tested to ensure they remain at clinically effective levels over time. Every formula is rigorously reviewed through full toxicology assessments—evaluating both the final product and individual ingredients for proven safety and efficacy. Clinical validation includes ophthalmology testing, HRIPT (Human Repeat Insult Patch Testing) for sensitive skin tolerance, and robust use and perception studies supported by before-and-after imagery. Formulated in Korea and developed under ISO 16128 guidelines for natural origin content, Circē products are crafted without parabens, phenoxyethanol, fragrance allergens, gluten, colorants, alcohol, PEGs, or silicones. Each formula features Circē’s proprietary organic adaptogenic blend to calm and nourish post-procedure skin while supporting barrier recovery. Designed for precision and compliance, products are pre-dosed for monthly use, making it easy for providers and patients to stay on protocol. Circē Skincare represents the intersection of clean innovation, clinical science, and patient-centric performance. YOUR BEST SKIN EVER. FOREVER™ CIRCĒ SKINCARE

Circē Skincare revenue & valuation

Annual revenue	$256,665
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$821,328
Total funding	No funding